SlideShare a Scribd company logo
PATHOLOGY OF ENDOCRINE
SYSTEM
2009
Dr. Huda M Zahawi, FRC.Path
The Endocrine system is divided into :
• Endocrine organs dedicated to production of
hormones e.g. pituitary,thyroid….etc
• Endocrine components in clusters in organs
having mixed functions e.g. pancreas, ovary,
testes…..
• Diffuse endocrine system comprising
scattered cells within organs acting locally
on adjacent cells without entry into blood
stream
Disease divided into :
1- Diseases of overproduction of secretion
( Hyperfunction )
2- Diseases of underproduction
( Hypofunction )
3- Mass effects ( Tumors )
N.B. Correlation of clinical picture , hormonal
assays , biochemical findings , together with
pathological picture are of extreme
importance in most conditions.
PITUITARY GLAND
PITUITARY GLAND
• Pituitary in sella turcica,& weighs about 0.5gm.
• Connected to the HYPOTHALAMUS with stalk.
• Composed of :
A-ADENOHYPOPHYSIS- (80%)
– Blood supply is through portal venous plexus
– Hypothalamic-Hypophyseal feed back control
B- NEUROHYPOPHYSIS
– From floor of third ventricle
– Modified glial cells & axons hypothalamus.
– Has its own blood supply.
CELLS & SECRETIONS :
A- Anterior pituitary ( Adenohypophysis )
1-Somatotrophs from acidophilic cells → Growth H.
2- Lactotrophs from chromophobe cells → Prolactin
3- Corticotrophs from basophilic cells → ACTH,MSH .
4- Thyrotrophs from pale basophilic cells → TSH
5- Gonadotrophs from basophilic cells → FSH, LH
B- Posterior pituitary ( Neurohypophysis )
1- Oxytocin
2- ADH
HYPERPITUITARISM & PITUITARY ADENOMA
In most cases, excess is due to ADENOMA
arising in the anterior lobe.
Less common causes include :
* Hyperplasia
* Carcinoma
* Ectopic hormone production
* Some hypothalamic disorders
Pathogenesis of pituitary adenomas :
• Mutations in G-proteins ( α subunit) in the GNAS1
gene on chromosome 20q13 lead to activation
• 40% of GH secreting adenomas & less in ACTH
• G-proteins involved in signal transduction :
GDP GTP cAMP
• Mutations in α subunit interfere with GTPase function
• Mutations in RAS, overexpression in C- MYC & NM23
inactivation found in more aggressive tumor
• Other mutations : MEN-1 gene ( Menin)
G proteins
GTPase
Features common to all pituitary adenomas :
• 10% of all intracranial neoplasms & 25% incidental
3% occur with MEN syndrome
• 30-50 years of age
• Primary pituitary adenomas usually benign
• May or may not be functional
• If functional, the clinical effects are secondary to the
hormone produced.
• More than one hormone may be produced by same
cell
• Although most are localized, invasive adenomas
erode sella turcica & extend into cavernous &
sphenoid sinus
CLINICAL FEATURES of PITUITARY ADENOMA:
1- Symptoms of hormone produced
2- Local mass effects :
i- Radiological changes
ii-Visual field abnormalities
iii-Elevated intracranial pressure
3- Hypopituitarism
4- Pituitary apoplexy
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
Mass effect of pituitary adenoma
Morphology of pituitary adenomas :
• Well circumscribed,invasive in up to 30%
• Size 1cm. or more, specially in nonfunctioning
tumor
• Hemorrhage & necrosis seen in large tumors
Microscopic picture :
• Uniform cells, one cell type (monomorphism)
• Absent reticulin network
• Rare or absent mitosis
Sella turcica with pituitary adenoma
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
Uniform cells of pituitary adenoma
Types of Pituitary Adenomas
• Previously classified according to histological
picture e.g :
Acidophilic Adenoma
• Now according to immunohistochemical
findings & clinical picture ….. e.g.
Growth hormone secreting adenoma
Immunoperoxidase for GH
1- PROLACTINOMA :
• 30% of all adenomas, chromophobe or weakly
acidophilic
• Functional even if small, but related to size
• Other causes of  prolactin include : estrogen
therapy, pregnancy, reserpine , hypothyroidism……
• Any mass in the suprasellar region may interfere
with normal prolactin inhibition   Prolactin
( STALK EFFECT )
• Mild elevation of prolactin does NOT always indicate
prolactin secreting adenoma !
Symptoms :
• Galactorrhea
• Amenorrhea
• Decrease libido
• Infertility
2- Growth hormone secreting adenoma :
• 40% Associated with GNAS 1 gene mutation
• Persistent secretion of growth hormone leads
to secretion of Insulin – like GF → symptoms
• Composed of granular ACIDOPHILIC cells
• May be mixed with prolactin secretion.
• Symptoms delayed so adenomas are usually
large
• Produce GIGANTISM or ACROMEGALLY
• Other symptoms : diabetes, arthritis, large
jaw & hands, osteo porosis, BP, HF…..etc
3- Corticotroph cell adenoma
• Usually microadenomas
• Higher chance of becoming malignant
• Chromophobe or basophilic cells
• Functionless or Cushing ‘s Disease (  ACTH )
• Bilateral adrenalectomy or destruction may
result in aggressive adenoma:
Nelson’s Syndrome
• Corticotroph microadenoma  Macroadenoma
•  ICP
4- Non functioning adenoma 20%
silent or null cell ,nonfunctioning & produce mass
effect only
5- Gonadotroph producing LH &FSH- ( 10-15%)-
Function silent or is minimal , late presentation
mainly mass effect produced.
Produce gonadotrophin α subunit, β- FSH & β-LH
6- TSH producing ,(1%) rare cause of
hyperthyroidism
7- Pituitary carcinoma - Extremely rare, diagnosed
only by metastases.
HYPOPITUITARISM :
• Loss of  75% of ant. Pituitary  Symptoms
• Congenital or acquired, intrinsic or extrinsic
• Symptoms include dwarfism, & effect of individual
hormone deficiencies. Loss of MSH → Decreased
pigmentation
• Acquired causes include :
1- Nonsecretory pituitary adenoma
2- Ischemic necrosis e.g.
SHEEHAN’S SYNDROME (post partum hmg.)
sickle cell anemia, DIC, Pituitary apoplexy…
3- Iatrogenic by radiation or surgery
4- Autoimmune ( lymphocytic) hypophysitis
5- Inflammatory e.g sarcoidosis or TB …..
6- Empty Sella Syndrome : Radiological term
for enlarged sella tursica, with atrophied or
compressed pituitary.
May be primary due to downward bulge of
arachnoid into sella floor compressing
pituitary.
Secondary is usually surgical.
7- Infiltrating diseases in adjacent bone e.g.
Hand Schuller – Christian Disease
8- Craniopharyngioma
Craniopharyngioma :
* 1-5 % of intracranial neoplasms
* Derived from remnants of Rathke’s Pouch
* Suprasellar or intrasellar ,often cystic with
calcification
* Children or adolescents most affected
* Symptoms may be delayed ≥ 20yrs( 50%)
* Symptoms of hypofunction or hyperfunction
of pituitary and /or visual disturbances,
diabetes insipidus
* Benign & slow growing
POSTERIOR PITUITARY SYNDROMES:
1-A- ADH deficiency causes Diabetes Insipidus
Excessive urination,dilute urine , due to
inability to reabsorb water from the
collecting tubules. Causes include head
trauma, tumors & inflammations in pituitary
or hypothalamus…etc.
B- Syndrome of inappropriate ADH secretion
Causes excessive resorption of water
hyponatremia e.g Small Cell CA of Lung
2-Abnormal oxytocin secretion :
Abnormalitis of synthesis & release have not
been associated with any significant
abnormality.
THYROID GLAND
• Development from evagination of pharyngeal
tissue into neck
• Abnormal descent Lingual thyroid ,
subhyoid, substernal
• Weight 15-20gm. Responsive to stress
• Structure : varying sized follicles lined by
columnar epithelium , filled with colloid,
interfollicular C cells
• Secretion of T3 & T4 is controlled by trophic
factors from hypothalamus & ant.pituitary
THYROTOXICOSIS:
• Hypermetabolic state caused by  T4, T3.
A- Associated with hyperthyroidism:
Primary : Graves Disease
Toxic multinodular goiter
Toxic adenoma
Secondary : TSH secreting pit. adenoma
B- Not associated with hyperthyroidism :
Thyroiditis
Struma ovarii
Exogenous thyroxine intake
Clinical Picture related to Sympathetic
Stimulation
• Constitutional symptoms : heat intolerance,
sweating, warm skin, appetite but ↓weight
• Gastrointestinal : hypermotility, malabsorption
• Cardiac : palpitation, tachycardia, CHF
• Menstrual disturbances
• Neuromuscular : Tremor, muscle weakness
• Ocular : wide staring gaze, lid lag, thyroid
ophthalmopathy
• Thyroid storm : severe acute symptoms of
sympathetic overstimulation
• Apathetic hyperthyroidism : incidental
Diagnosis of Hyperthyroidism :
• Measurement of serum TSH (↓ ) + free T4 is
the most useful screening test for
thyrotoxicosis
• TSH level is normal or  in secondary
thyrotoxicosis
• In some patients , T3 but T4 normal or ↓
• Measurement of Radioactive Iodine uptake is
a direct indication of activity inside the gland
Normal radioactive I uptake
HYPOTHYROIDISM :
Primary :
1- Loss of thyroid tissue due to surgery or
radiation Rx.
2- Hashimoto’s thyroiditis
3- Iodine deficiency specially in endemic areas
4- Primary idiopathic hypothyroidism
5- Congenital enzyme deficiencies
6- Drugs e.g. iodides, lithium…..
7- Thyroid dysgenesis ( developmental )
Secondary :
Pituitary or hypothalamic failure
Hypothyroidism is commoner in endemic areas
of iodine deficiency
CRETINISM : hypothyroidism in infancy & is
related to the onset of deficiency .
If early in fetal life Mental retardation ,
short stature, hernia, skeletal abnormalities,
MYXEDEMA in adults Apathy, slow mental
processes, cold intolerence,accumulation of
mucopolysaccharides in subcutaneous tissue
Lab.tests :  TSH in primary hypothyroidism,
unaffected in others T4 in both.
THYROIDITIS :
• Mostly autoimmune mechanisms
• Microbial infection is rare
• Types include :
1- Chronic lymphocytic ( Hashimoto’s )
thyroiditis
2- Subacute granulomatous ( de Quervain)
thyroiditis
3- Subacute lymphocytic thyroiditis
4- Riedel thyroiditis
5- Palpation thyroiditis
HASHIMOTO’s THYROIDITIS :
Chronic Lymphocytic Thyroiditis
• Autoimmune disease characterized by
progressive destruction of thyroid tissue
• Commonest type of thyroiditis
• Commonest cause of hypothyroidism in areas
of sufficient iodine levels
• F:M = 10-20 :1, 45-65 yrs.
• Can occur in children
Pathogenesis :
A - T cell sensitization to thyroid antigens
1- Sensitized CD4 T cells  Cytokine mediated
( IFN- γ)cell death inflammation,macrophage
activation
2- CD8+ cytotoxic T cell mediated cell death:
Recognition of AG on cell  killed
3- Presence of thyroid AB  Antibody dependent
cell mediated cytotoxicity by NK cells
B- Genetic predisposition :
↑ in relatives of 1st.degree
Association with HLA – DR 3 & DR- 5
Morphology:
• Gland is a smooth pale goitre, minimally
nodular, well demarcated.
• Microscopically :
- Dense infiltration by lymphocytes &
plasma cells
- Formation of lymphoid follicles, with
germinal centers
- Presence of HURTHLE CELLS
- With or without fibrosis
• Clinically :
– Painless symmetrical diffuse goiter
– May show initial toxicosis ( Hashitoxicosis ).
– Later marked hypothyroidism.
– Patients have  risk of B-Cell lymphoma
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
SUBACUTE GRANULOMATOUS
THYROIDITIS :
• Middle aged , more in females. Viral etiology ?
• Self-limited (6-8w)
• Acute onset of pain in the neck , fever,
 ESR,  WBC
• Transient thyrotoxicosis.
• Morphology :
– Firm gland.
– Destruction of acini leads to mixed inflammatory
infiltrate.
– Neutrophils , Macrophages & Giant cells &
formation of granulomas
SUBACUTE LYMPHOCYTIC THYROIDITIS :
(Silent)
• Middle aged females & post partum patients
• Probably autoimmune with circulating AB
• May recur in subsequent pregnancies
• May progress to hypothyroidism
• Histology similar to Hashimoto’s thyroiditis
without Hurthle cell metaplasia
• Reidel’s Thyroiditis –
Dense fibrosis without prominent inflammation
? Considered as fibromatosis rather than thyroiditis
GRAVE’S DISEASE :
• Commonest cause of endogenous
hyperthyroidism
• Age 20- 40 yrs.,
• M: F ratio is 1: 7
• More common in western races
Main features of GRAVES DISEASE :
1 - Thyrotoxicosis with smooth symmetrical
enlargement of thyroid
2 - Infiltrative ophthalmopathy with
exophthalmus in 40%
3- Pretibial myxedema in a minority
• Lab findings :  T4, T3 , TSH
• Radioactive study: Diffuse uptake of
radioactive I
Pathogenesis of GRAVE’S DISEASE :
• Genetic etiology + Autoimmune processes
• GENETIC EVIDENCE :
• May be familial
• 60% concordance in identical twins
• Susceptibility is associated with
HLA-B8 & - DR3
• May exist with other similar diseases e.g.
SLE, Pernicious anemia, Diabetes type I,
Addison’s dis.
IMMUNE MECHANISMS :
• Antibodies to thyroid peroxisomes & thyroglobulin
• Patients develop autoantibodies to TSH receptor
– Thyroid Stimulating Immunoglobulin ( TSI) binds
to TSH receptor → thyroxin ***
– Thyroid Growth Stimulating Immunoglobulin
(TGI) → proliferation of thyroid epithelium
– TSH binding inhibitor immunoglobulins (TBIIs)
prevent TSH from binding to receptor
• Both stimulation & inhibition may coexist
Morphology :
• Smooth enlargement of gland with diffuse
hyperplasia & hypertrophy
• Lining epithelium of acini :
Tall & hyperplastic ± papillae
• Colloid :
Minimal thin colloid with scalloped edge
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Changes in Extrathyroid tissue :
• Generalized lymphoid hyperplasia
• Ophthalmopathy : Edematous orbital
muscles &infiltration by lymphocytes
followed by fibrosis
• Thickening of skin & subcutaneous tissue
• Accumulation of glycosaminoglycans which
are hydrophilic
• Result :
Displacement of eyeball & exophthalmus →
redness, dryness, ulceration, infection in
conjunctiva
• Cause :
Expression of aberrant TSH receptor
responding to circulating anti TSH receptor
AB → inflammatory lymphocytic reaction
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 15 December 2005 07:30 AM)
© 2005 Elsevier
DIFFUSE NONTOXIC & MULTINODULAR GOITRE
GOITER = Enlargement of thyroid
Most common cause is iodine deficiency
impaired hormone synthesis TSH 
hypertrophy & hyperplasia of follicles  Goiter
Endemic :  10% of population have goiter
Sporadic : 1- Physiological demand
2- Dietary intake of excessive
calcium & cabbages…etc
3- Hereditary enzyme defects
MORPHOLOGY :
• Initially diffuse → nodular with degenerative
changes: colloid cysts, hemorrhage, fibrosis,
calcification
• If large may extend retrosternally
• Pressure symptoms are a common complaint
• Picture is that of varying sized follicles,
hemorrhage , fibrosis , cysts, calcification
• Patient is often EUTHYROID. but may be
toxic or hypofunctioning.
Normal radioactive I uptake
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
NODULES in the thyroid :
• Nodules in thyroid may be multiple or solitary
• Any solitary nodule in the thyroid has to be
investigated as some are neoplastic.
Investigations include FNA , Radioactive image
technique, Ultrasound, & (T4,T3 & TSH ) levels
• HOT nodule takes up radioactive substance
( functional)
• COLD nodule does not it take up
( nonfunctional )
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
General rules of nodules in the thyroid :
1- Solitary nodule is MORE likely to be
NEOPLASTIC than multiple
2- Hot nodules are more likely to be BENIGN
3- Not every cold nodule is malignant .
Many are nonfuctioning adenomas, or colloid
cysts , nodules of nodular goitre….etc
Up to 10% of cold nodules prove to be
malignant.
4- Nodules in younger patients are more likely
to be NEOPLASTIC
5- Nodules in males are more likely to be
NEOPLASTIC .
6- History of previous radiation to the neck is
associate with increased risk of malignancy
NEOPLASMS of the THYROID :
ADENOMAS:
• Usually single.
• Well defined capsule
• Commonest is follicular± Hurthle cell change
• May be toxic
• Size 1- 10cm. Variable colour
• Activating somatic mutation in TSH receptor is
identified leading to overproduction of cAMP
• 20% have point mutation in RAS oncogene
Microscopical Picture :
• 1- Uniform follicles , lined by cuboidal epithelial
cells.
• 2- Focal nuclear pleomorphism, nucleoli ….
( Endocrine atypia )
• 3- Presence of a capsule with tumor compressing
surrounding normal thyroid outside .
* Integrity of capsule is important in differentiating
adenoma from well differentiated follicular
carcinoma.
• Capsular and/ or vascular invasion →Carcinoma
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
© 2005 Elsevier
Adenoma with intact capsule
Capsular invasion)
CARCINOMAS of THYROID :
• Incidence about 1-2% of all malignancies.
• Wide age range ,depending on type.
• Generally commoner in females, but in
tumors occurring in children or elderly ,
equal incidence in both sexes.
• Most are derived from follicular cells
• Few are derived from ‘C’ cells
TYPES of THYROID CARCINOMA :
1- Papillary Carcinoma ( 75- 85% ),any age,but usual
type in children.
2- Follicular Carcinoma ( 10- 20% )More in middle age
3- Medullary Carcinoma ( 5% ) age 50-60 but younger
in familial cases with MEN syndrome
4- Anaplastic Carcinoma (  5% ) , old age
Presenting symptom is usually a mass , maybe
incidental in a multinodular goitre specially papillary,
& follicular
Pathogenesis of Thyroid Cancer :
1- Genetic lesions :
Most tumors are sporadic
Familial is mostly Medullary CA , Papillary CA
• Papillary CA :
– Chromosomal rearrangement in tyrosin
kinase receptor gene (RET) on chr.10q11 
ret/PTC  tyrosine kinase activity
( 1/5 of cases specially in children)
– Point mutation in BRAF oncogene (1/3-1/2)
• Follicular Carcinoma :
– RAS mutation in ½ of cases OR
– PAX8- PPAR γ 1 fusion gene in 1/3 of
cases
• Medullary Carcinoma :
– RET mutation  Receptor activation
• Anaplastic Carcinoma :
– Probably arising from dedifferentiation of
follicular or papillary CA  inactivation of
P53
2- Environmental Factors :
• Ionizing radiation specially in first two
decades
• Most common is Papillary CA. with RET
gene rearrangement
3- Preexisting thyroid disease :
• Incidence of thyroid CA is more in endemic
areas
• Long standing multinodular goiter →
Follicular CA
• Hashimotos thyroiditis → Papillary CA &
B cell lymphoma
• TYPES OF THYROID CARCINOMAS
PAPILLARY CARCINOMA :
• Cold on Scan by radioactive Iodine
• Solitary or multifocal
• Solid or cystic,  calcification
• Composed of papillary architecture
• Less commonly ‘Follicular Variant’
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Diagnosis based on NUCLEAR FEATURES
• Nuclei are clear (empty) ,with grooves &
inclusions ( Orphan Annie nuclei)
• Psammoma bodies
• Metastases mainly by L.N., sometimes from
occult tumor
• Hematogenous spread late & prognosis is
GOOD
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
FNA of Papillary CA (nuclear changes)
Psammoma body in Papillary CA
FOLLICULAR CARCINOMA :
• Usually cold but rarely functional ( warm )
• Well circumscribed with thick capsule
(minimally invasive) or diffusely infiltrative
• Composed of follicles , sometimes of
Hurthle Cells
• Diagnosis is based on CAPSULAR &
VASCULAR invasion
• Metastasize usually by blood  Lungs,
Bone, Liver ..etc.
• Treatment by surgery  Radioactive Iodine
 Thyroxin
• Prognosis is not as good as papillary except
in minimally invasive very well differentiated
forms
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Follicular Carcinoma
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Capsular invasion)
MEDULLARY CARCINOMA:
• Arise from C cells  CALCITONIN, CEA,
serotonin, VIP
• 80% Sporadic , or familial  MEN Syndrome
• Composed of polygonal or spindle cells ,
usually with demonstrable AMYLOID in the
stroma
• Calcitonin demonstrated in tumor cells
• Level of calcitonin in serum may be useful
for follow up
• Family members may show C cell
hyperplasia ,↑ Calcitonin, & RET mutation
( Marker for early diagnosis)
• Metastases by blood stream
• Prognosis intermediate , worse in MEN. 2B
Medullary CA with amyloid
Congo red for amyloid
ANAPLASTIC CARCINOMA :
• Elderly patients with multinodular goitre in
50%
• Foci of papillary or follicular CA may be
present in 20%- 30% , probable
dedifferentiation process
• Markedly infiltrative tumor , invading the
neck → pressure on vital structures
• Rapid progression, death within 1 year
• Morphology : Composed of pleomorphic
giant cells, spindle cells or small cell
anaplastic varients, which may be confused
with lymphoma
• Radiosensitive tumor , no surgery
• P53 mutation identified , consistent with
tumor progression
PARATHYROID GLAND
• Derived from the third and fourth pharyngeal pouches.
• 90% of people have four glands.
• Location: mostly close to the upper or lower poles of
the thyroid.
• Can be found anywhere along the line of descent of
the pharyngeal pouches.
• There are two types of cells with intervening fat :
- Chief & Oxyphil cells
• Secretion of PTH is controlled by level of free calcium
Hyperparathyroidism : Primary OR Secondary
Primary Hyperparathyroidism:
• Commonest cause of asymptomatic hypercalcemia
• Female:Male ratio = 2-3 : 1.
• Causes : Adenoma 75%-80%
Hyperplasia 10-15%
Carcinoma < 5%
• Majority of adenomas are sporadic
• 5% familial associated with MEN-1 or MEN-2A
Genetic abnormalities :
• PRAD 1 on chromosome 11 q  cell cycle
control  cyclin D1 overexpression(10%-20%)
• MEN 1 on 11q13 is a cancer suppressor gene
- Germ line mutation in MEN-1 syndrome
 loss of function  cell proliferation
- *20% - 30% of sporadic cases may also show
mutation of MEN1
*Either of above may cause tumor or hyperplasia
• Biochemical findings :
PTH ,  Ca , ↓ phosphate ,alkaline
phosphatase
• In other causes of hypercalcemia, PTH is ↓
Gland morphology in Hyperparathyroidism
• Adenomas :
• Usually single , rarely multiple
• Well circumscribed, encapsulated nodule
(0.5-5g.)
• The cells are polygonal, uniform chief cells,
few oxyphil cells. Adipose tissue is minimal in
the tumor
• Compressed surrounding parathyroid tissue in
periphery, other glands normal or atrophic .
• Hyperplasia :
Enlargement of all 4 glands.
Microscopically chief cell hyperplasia, or clear
cell, usually, in a nodular or diffuse pattern.
Note : Diagnosis of adenoma versus hyperplasia
may depend on the size of the other glands
Parathyroid carcinoma :
• Larger than adenoma (5-10g)
• Very adherent to surrounding tissue.
• Pleomorphism & mitoses not reliable criteria
for malignancy
• Most reliable criteria for malignancy are :
* Invasion
**Metastases
Morphology in other organs:
• Skeletal system:
– Bone resorption by osteoclasts, with fibrosis, cysts
formation and hemorrhage Osteitis Fibrosa
Cystica
– Collections of osteoclasts form ‘ Brown Tumors”
– Chondrocalcinosis and pseudogout may occur.
• Renal system:
– Ca. Stones. & Nephrocalcinosis.
• Metastatic calcification in other organs:
Blood vessels & myocardium , Stomach, Lung …etc
Hyperparathyroidism, clinical picture
• 50% of patients are asymptomatic.
• Patients show  Ca & PARATHORMONE levels in
serum
• Symptoms and signs of hypercalcemia:
Musculoskeletal, Gastrointestinal tract, Urinary
and CNS symptoms
• Commonest cause of silent hypercalcemia .
• In the majority of symptomatic hypercalcemia
commonest cause is wide spread metastases to bone
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Painful Bones, Renal Stones, Abdominal Groans & Psychic Moans
Secondary Hyperparathyroidism :
• Occur in any condition associated with chronic
hypocalcemia, mostly chronic renal failure.
• Glands are hyperplastic
• Renal failure phosphate excretion 
increased serum phosphate,  CaPTH
Tertiary Hyperparathyroidism
• Extreme activity of the parathyroid 
autonomous function & development of
adenoma (needs surgery)
Hypoparathyroidism :
• Causes:
– Damage to the gland or its vessels during
thyroid surgery.
– Idiopathic, autoimmune disease.
– Pseudohypoparathyroidism, tissue
resistance to PTH
• Clinical features:
-Tetany, convulsion, neuromuscular
irritability, cardiac arrhythmias……
ENDOCRINE PANCREAS
• Diseases mainly include :
– Diabetes
– Islet Cell Tumors
DIABETES
DIABETES :
• Chronic disorder in which there is abnormal
metabolism, of carbohydrate, fat & protein ,
characterized by either relative or absolute
insulin deficiency, resulting in hyperglycemia.
• Most important stimulus that triggers insulin
synthesis from β cells is GLUCOSE
• Other agents stimulate insulin release
• Level of insulin is assessed by the level of
C - peptide
• Diagnosis :
1- Random glucose ≥ 200g / dL + symptoms
2- Fasting glucose of ≥ 126 / dL on more
than one occasion
3- Abnormal OGTT when glucose level is
more than 200g / dL 2hrs. after standard
glucose load of 75 g.
Classification :
Causes could be Primary in the pancreas OR
secondary to other disease conditions
Primary diabetes is classified into :
A- Type 1
B- Type 2
C- Genetic & Miscellaneous causes
Whatever the type, complications are the same
Type 1 :-
• Absolute deficiency of insulin due to β cell
destruction ( 10%)
•  90% of  cells lost before metabolic
changes appear
• Age ≤ 20 yrs but may be latent
• Normal or decreased weight
• Ketoacidosis is common
Type 2 :
• Due to a combination of peripheral
resistance to insulin action & inadequate
secretory response by the pancreatic β cells
• Commoner ( 80 - 90% )
• Insulin normal (relative insulin deficiency)
• Patient is overweight
• Rare ketoacidosis
Type 3 : Miscellaneous causes
• Genetic defects :
– β cell function
e.g. Maturity Onset Diabetes of the Young
( MODY)caused by a variety of mutations
– Genetic defects of insulin processing or
action
e.g. Insulin gene or Insulin receptor
mutations
Secondary Miscellaneous Causes :
• Diseases of exocrine pancreas e.g. chronic
pancreatitis
• Endocrinopathies e.g. Cushing’s Syndrome,
Acromegally
• Infections e.g. CMV
• Drugs e.g. glucocorticoids
• Gestational diabetes
• Other genetic syndromes associated with
diabetes
PATHOGENESIS
Pathogenesis of Type 1 Diabetes :
1- Genetic susceptibility
2- Autoimmunity
3- Environmental factors
It is a combination of autoimmunity &
environmental insult in a person with a
known genetic susceptibility leading to
destruction of β cells
1- Genetic susceptibility
– Principal susceptibility genes located in
region of MHC class II on chromosome 6p21
– 90% Associated with HLA- DR3,or HLA-
DR4, or both
– Racial predisposition, (Caucasians) but
majority have no family history
– 6- 20% familial ,< 40% in identical twins
– Second susceptibility gene encodes a T cell
inhibitory receptor (CTLA-4) interfering with
normal T cell function
2- Autoimmunity -
• Presence of CD 8+ & CD 4+ in islet cells
“ Insulinitis”
• Presence of islet cell antibodies ( insulin &
GAD) in 80% of patients & in relatives several
months or years before onset
• Antibodies are highly selective against β cells
• Relatives at risk have similar AB years before
onset
• 10% - 20% other autoimmune disease
3- Environmental factors
An environmental insult may damage β cells
rendering them antigenic.
• Viruses : measles , coxsackie , rubella
• Chemicals
• Cow’s milk
Pathogenesis of Type 2 diabetes :
1- Genetic factors
2- Insulin resistance & obesity
3 - cell secretion dysfunction
1- Genetic factors :
– Genetic factors are more important than in
type 1 diabetes, but this is multifactorial
– 50% - 90% in identical twins
–  risk by 20%-40% in first degree relatives
– No association with HLA & no autoimmune
basis
– Point mutation in insulin receptor identified
affecting signaling pathway but rare ( 1-5%)
2 – Insulin resistance :
• Decrease ability of peripheral tissue to
respond to insulin
Early : insulin resistance →  insulin
secretion due to compensatory  of  cell
mass
Later : relative  insulin &   cell mass to
20-50%
MAIN FACTOR IN INSULIN RESISTANCE IS
OBESITY
Explanation :
• Adipocytokines :
– Resistin ↑ obesity → Insulin resistance
– Leptin & Adiponectin contribute to insulin
sensitivity but are ↓in obesity → resistance
– PPAR γ is a nuclear receptor that regulates
level of adipocytokines
– FFA in tissues (lipotoxic effect) →
 insulin resistance
3-  cell Dysfunction :
• Defective glucose recognition due to ↑ intracellular
levels of a mitochondrial protein ( UCP2) in β cells
• Amylin :
A protein normally produced by  cells secreted with
insulin in response to food ingestion
Amylin accumulates outside  cells, forming amyloid
like deposits & may impair  cell glucose sensing.
Seen in up to 90% of cases of Type II diabetes
Pathogenesis of complications :
1- Nonenzymatic glycosylation of proteins
Glucose + Free amino acids
Later → Irreversible combination
Advanced Glycosylation End products =AGES
Measured by level of glycosylated Hb
( HbA1c)
AGES inactivate proteins & cross link with
more proteins, deposited in vessels,
renal glomeruli, …..etc
Effects :
Induce cytokine production, GF :
• ↑ vascular permeability
• ↑ procoaggulant activity
• ↑ fibroblasts & SM in ECM
Complications in blood vessels, kidney,
nervous system ….etc
Complications are proportional to the degree
of hyperglycemia of whatever type
2- The Polyol Pathway
Persistent hyperglycemia facilitates entry
of glucose & its accumulation into some
cells & metabolized into 
SORBITOL (a polyol) &
FRUCTOSE
Creation of osmotic gradient  Influx of
fluid + Toxic
lens, retina, peripheral nerves, kidney…etc
3- Activation of Protein Kinase C :
• Activation of signal transduction
• Leads to production of pro-angiogenic
factors (VEGF)
Important in retinal neovascularization
• Production of pro-fibrogenic factors → ↑ECM
& BM thickening
COMPLICATIONS
Pathology in the Pancreas
i -Type I :
- Leukocytic infiltration of islets ( T cells)
‘Insulinitis’ with progressive depletion of
 cells.
- Later small indistinct or absent islets.
ii - Type II :
- Ill defined reduction in islet cell mass
- Fibrous tissue accumulation in some islets
- Amyloid deposition in islets
• Newborn of diabetic mother : islet cell hyperplasia
COMPLICATIONS
1- Atherosclerosis :
- Cardiovascular
- CNS complications
- Peripheral circulation
2- Diabetic microangiopathy
- Hyaline arteriolosclerosis , exaggerated in
hypertension
- Diffuse thickening in capillaries of skin, retina
peripheral nerves, renal medulla → Leaky
vessels→ nephropathy, retinopathy, neuropathy
3- Diabetic nephropathy
I - Glomerular lesions-
- Capillary BM thickening
- Nodular glomerulosclerosis 15% -30%
( Kimmelstiel - Wilson lesion)
- Diffuse mesangial sclerosis
II - Renal vascular lesions
- Renal atherosclerosis
- Hyaline arteriolosclerosis
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Kimmelstiel- Wilson lesion
III – Pyelonephritis
- Acute & chronic interstitial inflammation
- Necrotizing papillitis / papillary necrosis
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
4- Ocular complications :
I - Retinopathy :
- Nonproliferative : hemorrhage, exudate,
microaneurysm, edema…
- Proliferative : Neovascularization, fibrosis,
retinal detachment
II - Cataract formation
III - Glaucoma
5- Diabetic neuropathy
I - Peripheral sensory & autonomic nerve dysfunction
( microangiopathy & demyelination )
II - Neuronal degeneration
III - Degenerative spinal cord lesions
6- Recurrent infections : Bacterial & mycotic
• Clinical Features in Diabetes :
Type 1 :
• Age < 20 , but some are latent (LADA)
• May present with metabolic acidosis, weight
loss, dehydration,& electrolyte imbalance.
Polyuria , Polydipsia, Polyphagia ( 3P’s)
• Findings : - Hyperglycemia
- Glucosuria ± Ketonuria
- Electrolyte imbalance
Type 2 :
• Age > 40yrs., often present incidentally
• Patients may have the 3 P’s  symptoms of
complications
• Hyperosmolar nonketotic coma caused by
dehydration due to uncompensated
hyperglycemic diuresis.
• No keto acidosis
• Increased susceptibility to infections
ISLET CELL TUMORS
Islet Cells & Secretions :
• β cells  insulin
• α cells  glucagon
• δ cells  somatostatin
• Pancreatic polypeptide ( PP)  VIP
Islet Cell Tumors of Pancreas :
• Include insulinomas, gastrinomas,
glucagonomas….etc
• Less frequent than pancreatic CA
• Maybe functioning or nonfunctioning
• Tumors ≤ 2 cm. diameter likely to be benign
• Associated clinical syndromes :
1- Hyperinsulinism (Insulinomas)
2- Zollinger - Ellison Syndrome
( Gastrinomas)
3- Multiple endocrine neoplasia (MEN)
Insulinoma :
• Commonest type
• Hypoglycemia ≤ 50 mg./dl.
• Attack precipitated by fasting or exercise, relieved by
eating or glucose administration
• Lab. :  serum glucose , serum insulin
• Most tumors in pancreas but can be ectopic
• Most tumors solitary ( < 2cm.), can be multiple
• Majority are benign, 10% can be malignant
• Histologically difficult to diagnose malignancy
Gastrinomas :
• More in middle aged females
• Located in pancreas , duodenum or peripancreatic
tissue
• Single or multiple, or associated with other tumors
• > 50% locally invasive or have metastasized at
diagnosis
• Present with Zollinger- Ellison Syndrome
Zollinger - Ellison Syndrome :
– Peptic ulcer disease
– Ulcer features :
Multiple ulcers
Unusual locations specially jejunum
Intractable
– Gastrin hypersecretion
– Diarrhea in > 50% & may be the presenting
symptom
Rare tumors :
• α- Cell tumors : Middle aged women
Glucagon secretion , mild diabetes, skin
rash, anemia
• δ- Cell tumors : Somatostatin secretion 
Diabetes, malabsorption, GB stones…
• VIPomas : VIP secretion 
Watery diarrhea, hypokalemia, achlorhydria
ADRENAL GLAND
ADRENAL GLAND
• Weight of normal gland is 4 gm.
Adrenal Cortex - Derived from mesoderm & composed
of
1- Zona glomerulosamineralocorticoids (aldosteron)
2- Zona fasciculata  glucocorticoids ( cortisol )
3- Zona reticularis  estrogens & androgens
• Diseases are those of hyperfunction & hypofunction
& tumors
Adrenal Medulla –
• Derived from neural crest & is part of sympathetic
system.
• Composed of Chromaffin cells secreting catecholamines
• Diseases are mainly tumors
Congenital Anomalies
• Incidental finding of adrenal tissue in the
inguinoscrotal path , mainly in males
• Fusion of adrenals
• Congenital adrenal hyperplasia
• Ectopic tissue in adrenal : liver, thyroid & ovarian
tissue
ADRENOCORTICAL HYPERFUNCTION :
• There are 3 syndromes associated with hyperfunction:
1- Cushing’s Syndrome & Cushing’s Disease
2- Conn’s Syndrome & Hyperaldosteronism
3- Adrenogenital Syndrome
CUSHING’Syndrome
• Elevation of cortisol level , which occurs in one of four
ways
A- Endogenous causes :
i- ACTH*secreting pituitary microadenoma, few
macroadenomas, OR hyperplasia
(CUSHING’s DISEASE)
ii-Adrenal tumor or hyperplasia
iii- Paraneoplastic syndrome
B- Exogenous cause :
Steroid Therapy
Tests used are :
Level cortisol in plasma,or excretion of 17hydroxy
steroids in urine, diurnal pattern , level of ACTH, &
Dexamethasone Suppression test.
Morphology of adrenals in Cushing’s Syndrome :
• This depends on the cause :
1- Exogenous increase glucocorticoids ACTH
Bilateral atrophy of adrenals
2 -Endogenous hypercorticolism:
a- Presence of adrenal adenoma or carcinoma,
with atrophy of adjacent & contralateral adrenal
b- Secondary to ACTH secreting adenoma
bilateral diffuse or nodular hyperplasia
c- Primary adrenal nodular hyperplasia
The pituitary in all forms of Cushing’s syndrome shows
Alteration in ACTH producing cells :
• Granular basophilic cells show lighter homogenized
cytoplasm due to accumulation of intermediate keratin
filaments in cytoplasm , called :
• Crooke’s Hyaline Change
Clinical features of Cushing’s syndrome :
Main symptoms include :
Central obesity/ moon face
Hypertension
Hirsutism/ menstrual disturbances
Diabetes
Osteoporosis
Increased risk of infections
Pigmentation of skin
HYPERALDOSTERONISM :
• Excess level of aldosterone cause sodium retension,
potassium excretion, resulting in hypertension &
hypokalemia.
• Type could be primary OR secondary
A- Primary : Conn Syndrome
• Caused by Adenoma (80%) F:M is 2:1
Single or multiple
• Or primary adrenal hyperplasia ( 15% ) ,
• Carcinoma is rare
• Adjacent adrenal cortex is NOT atrophic
• There is aldosteron Na retention & K excretion
 BP , Hypokalemia , RENIN
Correctable cause of HYPERTENSION
B- Secondary :
Due to decreased renal perfusion,
activation of the renin - angiotensin system 
aldosteron
• Differentiate from primary by  RENIN
VIRILIZING Syndromes :
Could be caused by - primary gonadal disorders
- Adrenocortical Neoplasms
- Congenital adrenal hyperplasia
• Neoplasms can occur at any age, frequently malignant
• Congenital adrenal hyperplasia is caused by an enzyme
defect in cortisol synthesis (21 hydroxylase)
NO CORTISOLACTH androgenic steroids
• Virilization , precocious puberty, ambiguous genitalia
• Patients have risk for acute adrenocortical insufficiency
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
MORPHOLOGY in ALL ADRENAL TUMORS:
• Encapsulated , usually yellow
• Size variable 1-2 cm. ( 30gms.)Up to large tumors
• Most incidental nonfunctioning tumors, may be
functioning
• Malignant tumors with necrosis, hemorrhage (≥ 300gms)
• Usually larger , more aggressive in adults
• Both may show same appearance of uniform or slightly
pleomorphic cells ,may be eosinophilic or clear
• Local invasion ,& the presence of metastases
differentiate benign from malignant tumors
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Cortical Adenoma
Adrenocortical carcinoma
ADRENOCORTICAL INSUFFICIENCY :
• May be primary adrenal or secondary to destruction of
the pituitary as in SHEEHAN’s syndrome….etc
• Primary in adrenal may be :
A- Acute :
1- Massive adrenal hemorrhage as in anticoaggulant
therapy, DIC, sepsis by N.meningitidis,pseudomonas
( Waterhouse- Friderichsen syndrome)
2- Sudden withdrawal of steroid therapy
3- Stress in a pt.with underlying chronic insufficiency
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Adrenal hemorrhage
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Adrenal insufficiency (continued )
B- Chronic :( Addison’s disease )
Progressive destruction of the adrenal by :
1- Autoimmune Disorder: 75-90 % , may be sporadic
or familial, linked to HLA-B8 , DR3, HLA-DQ5
Often multisystem involvement
2- Infections e.g. Tuberculosis , fungii ( AIDS)
3- Metastatic tumors destroying adrenal e.g. lung,
breast , …others
Morphology & Clinical features in Chronic Adrenal
Insufficiency :
• Morphology depends on cause :
• Autoimmune :
Irregular small glands, cortex infiltrated by lymphocytes,
medulla normal.
• T.B. Caseating Granuloma
• Metastatic disease  Type of primary tumor
• Secondary to pituitary cause : the adrenal is shrunken
• Clinical features :
Weight loss, hypotension, hypoglycemia, pigmentation….
There is Hyperkalemia & Hyponatremia due to
↓ mineralocorticoids
THE ADRENAL MEDULLA :
• Composed of CHROMAFFIN CELLS & nerve endings
• Secretetes cholamines in response to sympathetic
stimulation
• Also present in extra-adrenal sites
• Pathology includes tumors :
A- Pheochromocytoma
B- Neuroblastoma
PHEOCHROMOCYTOMA :
• Secretes catecholamines → VMA
• Sometimes described as The 10% Tumor because :
* 10% bilateral
* 10% extra adrenal ( Paraganglioma)
* 10% familial, maybe part of MEN syndrome
* 10% Malignant
• Usually well circumscribed,small to large in size,maybe
pleomorphic. Malignancy confirmed by METASTASES
• Clinically sustained or paroxysmal attacks of  BP
• CORRECTABLE cause of HYPERTENSION
Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)
© 2005 Elsevier
Pheochromocytoma
NEUROBLASTOMA :
• Commonest extracranial solid tumor of childhood
• Usually adrenal but maybe extra-adrenal
• Familial or sporadic
• Associated with deletion of short arm of chromosome 1
• 90% associated with catecholamine secretion
• VMA excreted in 24 hr. urine helpful in diagnosis.
• Morphologically it is composed of small round blue cells
which may differentiate to ganglion cells
• Spread to adjacent organs, lymph nodes, renal vein.
• Prognosis : STAGE , AGE , N myc amplification
MULTIGLANDULAR SYNDROMES
POLYGLANDULAR SYNDROME :
• Autoimmune disease
• Familial or sporadic
– Isolated involvement of adrenals
– Multiorgan involvement
• Type I : autosomal recessive associated with mutation
on immune regulator gene on Chr. 21
• Type II : multifactorial, linked to
HLA-B8 , HLA-DR3 , HLA-DQ5
– Include Hashimoto’s thyroiditis,adrenalitis, diabetes type I,
pernicious anemia
MEN SYNDROME :
• Inherited syndrome with multiple endocrine tumors &
or hyperplasia of component cells
• Tumors occur at younger age
• Often preceded by asymptomatic OR symptomatic
hyperplasia in involved organ
• Tumors may be multifocal in the same organ
• Often more aggressive than the same tumor without
MEN syndrome
Types of MEN syndromes :
• Type MEN 1 : ( 3 Ps)
• Autosomal dominant
• Involves suppressor gene on 11q.13
– Parathyroid : multiglandular parathyroid
hyperplasia (95%]
– Pancreas: aggressive,multifocal functional
gastrinomas & insulinomas
– Pituitary: Prolactinoma ± GH
Type MEN 2 :
• Autosomal dominant Proto-oncogen mutation :
RET/10q 11
• MEN 2 A :
– Medullary carcinoma of thyroid + C cell hyperplasia
– Pheochromocytoma (50%)
– Parathyroid hyperplasia
• MEN 2 B :
– As above but no parathyroid hyperplasia
– Extra endocrine manifestations :
e.g. mucosal neurofibromas
Pathology of Endocrine system.ppt

More Related Content

What's hot

Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
Aseem Jain
 
Pathology of Lower Urinary Tract & Male Genital System
Pathology of Lower Urinary Tract & Male Genital SystemPathology of Lower Urinary Tract & Male Genital System
Pathology of Lower Urinary Tract & Male Genital System
Nilay Nishith
 
Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
SCGH ED CME
 
Acromegaly - Clinical Round
Acromegaly - Clinical RoundAcromegaly - Clinical Round
Acromegaly - Clinical Round
Usama Ragab
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
TONY SCARIA
 
History taking and clinical examination of endocrine system
History taking and clinical examination of endocrine systemHistory taking and clinical examination of endocrine system
History taking and clinical examination of endocrine system
drkar
 
Adrenogenital syndrome
Adrenogenital syndromeAdrenogenital syndrome
Adrenogenital syndrome
Abdulmoein AlAgha
 
Investigation of endocrine glands
Investigation of endocrine glandsInvestigation of endocrine glands
Investigation of endocrine glands
ALAUF JALALUDEEN
 
Madhuri ppt path
Madhuri ppt pathMadhuri ppt path
Madhuri ppt path
Madhuri Reddy
 
Disorders of adrenal gland
Disorders of adrenal glandDisorders of adrenal gland
Disorders of adrenal gland
GAMANDEEP
 
Bethesda system for reporting
Bethesda system for reportingBethesda system for reporting
Adrenal Pathology
Adrenal PathologyAdrenal Pathology
Adrenal Pathology
Evith Pereira
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
Dr Niharika Singh
 
Laboratory investigations in pancytopenia
Laboratory investigations in pancytopeniaLaboratory investigations in pancytopenia
Laboratory investigations in pancytopeniaVeena Raja
 
Endocrine DIseases
Endocrine DIseasesEndocrine DIseases
Endocrine DIseases
Aubreyvale Sagun
 
Adrenal gland diseases and tumors
Adrenal gland diseases and tumorsAdrenal gland diseases and tumors
Adrenal gland diseases and tumors
MD Patholgoy, AFMC
 
1. pitutary disoreder hypo &amp; hper
1. pitutary disoreder hypo &amp; hper1. pitutary disoreder hypo &amp; hper
1. pitutary disoreder hypo &amp; hper
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110pjaffey
 

What's hot (20)

Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
 
Pathology of Lower Urinary Tract & Male Genital System
Pathology of Lower Urinary Tract & Male Genital SystemPathology of Lower Urinary Tract & Male Genital System
Pathology of Lower Urinary Tract & Male Genital System
 
Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
 
Acromegaly - Clinical Round
Acromegaly - Clinical RoundAcromegaly - Clinical Round
Acromegaly - Clinical Round
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
 
History taking and clinical examination of endocrine system
History taking and clinical examination of endocrine systemHistory taking and clinical examination of endocrine system
History taking and clinical examination of endocrine system
 
Adrenogenital syndrome
Adrenogenital syndromeAdrenogenital syndrome
Adrenogenital syndrome
 
Acromegaly
AcromegalyAcromegaly
Acromegaly
 
Investigation of endocrine glands
Investigation of endocrine glandsInvestigation of endocrine glands
Investigation of endocrine glands
 
Madhuri ppt path
Madhuri ppt pathMadhuri ppt path
Madhuri ppt path
 
Disorders of adrenal gland
Disorders of adrenal glandDisorders of adrenal gland
Disorders of adrenal gland
 
Bethesda system for reporting
Bethesda system for reportingBethesda system for reporting
Bethesda system for reporting
 
Adrenal Pathology
Adrenal PathologyAdrenal Pathology
Adrenal Pathology
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
 
Laboratory investigations in pancytopenia
Laboratory investigations in pancytopeniaLaboratory investigations in pancytopenia
Laboratory investigations in pancytopenia
 
Endocrine DIseases
Endocrine DIseasesEndocrine DIseases
Endocrine DIseases
 
Precocious puberty
Precocious pubertyPrecocious puberty
Precocious puberty
 
Adrenal gland diseases and tumors
Adrenal gland diseases and tumorsAdrenal gland diseases and tumors
Adrenal gland diseases and tumors
 
1. pitutary disoreder hypo &amp; hper
1. pitutary disoreder hypo &amp; hper1. pitutary disoreder hypo &amp; hper
1. pitutary disoreder hypo &amp; hper
 
Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110
 

Similar to Pathology of Endocrine system.ppt

Lecture 1. hyperpituitarism
Lecture 1. hyperpituitarismLecture 1. hyperpituitarism
Lecture 1. hyperpituitarism
Ayub Abdi
 
HYPOPITUITARISM.pptx
HYPOPITUITARISM.pptxHYPOPITUITARISM.pptx
HYPOPITUITARISM.pptx
GENERALMEDICEGDMC
 
Disorders of pituitary gland (( THE MASTER )) BY M.SASI
Disorders of pituitary gland (( THE MASTER  )) BY M.SASIDisorders of pituitary gland (( THE MASTER  )) BY M.SASI
Disorders of pituitary gland (( THE MASTER )) BY M.SASI
cardilogy
 
Pituitary april-12 د فائزة
Pituitary april-12 د فائزة Pituitary april-12 د فائزة
Pituitary april-12 د فائزة
eliasmawla
 
PARATHYROID BY AFZAL.pptx
PARATHYROID BY AFZAL.pptxPARATHYROID BY AFZAL.pptx
PARATHYROID BY AFZAL.pptx
afzal mohd
 
Hypopituitarism diagnosis and management (1)
Hypopituitarism diagnosis and management (1)Hypopituitarism diagnosis and management (1)
Hypopituitarism diagnosis and management (1)
rajeetam123
 
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
KomeraSivaramaprasad
 
HYPOTHYROID
HYPOTHYROIDHYPOTHYROID
HYPOTHYROID
Abhinav Srivastava
 
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
College of Medicine, Sulaymaniyah
 
Endocrine disorders ppt
Endocrine disorders pptEndocrine disorders ppt
Endocrine disorders ppt
pamtutor
 
Endocrine disorders ppt
Endocrine disorders pptEndocrine disorders ppt
Endocrine disorders ppt
pamtutor
 
endocrine lecture.pdf
endocrine lecture.pdfendocrine lecture.pdf
endocrine lecture.pdf
NimonaAAyele
 
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONEGIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
Arif S
 
Medicine 5th year, all lectures/pituitary (Dr. Sabir)
Medicine 5th year, all lectures/pituitary (Dr. Sabir)Medicine 5th year, all lectures/pituitary (Dr. Sabir)
Medicine 5th year, all lectures/pituitary (Dr. Sabir)
College of Medicine, Sulaymaniyah
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
CzarinaSales
 
Adrenal disorder.pptx
Adrenal disorder.pptxAdrenal disorder.pptx
Adrenal disorder.pptx
ssuserf8bb47
 
Pituitary gland
Pituitary glandPituitary gland
Pituitary gland
DORCAS NGUGI
 
Paraneoplastic Endocrine Syndrome
Paraneoplastic Endocrine SyndromeParaneoplastic Endocrine Syndrome
Paraneoplastic Endocrine Syndrome
DJ CrissCross
 
Pitutary part 1
Pitutary part 1Pitutary part 1
Pitutary part 1
drprakashshende1979
 
Pituitary tumours
Pituitary tumoursPituitary tumours

Similar to Pathology of Endocrine system.ppt (20)

Lecture 1. hyperpituitarism
Lecture 1. hyperpituitarismLecture 1. hyperpituitarism
Lecture 1. hyperpituitarism
 
HYPOPITUITARISM.pptx
HYPOPITUITARISM.pptxHYPOPITUITARISM.pptx
HYPOPITUITARISM.pptx
 
Disorders of pituitary gland (( THE MASTER )) BY M.SASI
Disorders of pituitary gland (( THE MASTER  )) BY M.SASIDisorders of pituitary gland (( THE MASTER  )) BY M.SASI
Disorders of pituitary gland (( THE MASTER )) BY M.SASI
 
Pituitary april-12 د فائزة
Pituitary april-12 د فائزة Pituitary april-12 د فائزة
Pituitary april-12 د فائزة
 
PARATHYROID BY AFZAL.pptx
PARATHYROID BY AFZAL.pptxPARATHYROID BY AFZAL.pptx
PARATHYROID BY AFZAL.pptx
 
Hypopituitarism diagnosis and management (1)
Hypopituitarism diagnosis and management (1)Hypopituitarism diagnosis and management (1)
Hypopituitarism diagnosis and management (1)
 
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
22-Parathyroid Disorders.ppt.pdf and parathyroid carcinoma
 
HYPOTHYROID
HYPOTHYROIDHYPOTHYROID
HYPOTHYROID
 
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
 
Endocrine disorders ppt
Endocrine disorders pptEndocrine disorders ppt
Endocrine disorders ppt
 
Endocrine disorders ppt
Endocrine disorders pptEndocrine disorders ppt
Endocrine disorders ppt
 
endocrine lecture.pdf
endocrine lecture.pdfendocrine lecture.pdf
endocrine lecture.pdf
 
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONEGIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
GIGANTISM,AND OTHER ENDOCRINE DISEASES OF BONE
 
Medicine 5th year, all lectures/pituitary (Dr. Sabir)
Medicine 5th year, all lectures/pituitary (Dr. Sabir)Medicine 5th year, all lectures/pituitary (Dr. Sabir)
Medicine 5th year, all lectures/pituitary (Dr. Sabir)
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
Adrenal disorder.pptx
Adrenal disorder.pptxAdrenal disorder.pptx
Adrenal disorder.pptx
 
Pituitary gland
Pituitary glandPituitary gland
Pituitary gland
 
Paraneoplastic Endocrine Syndrome
Paraneoplastic Endocrine SyndromeParaneoplastic Endocrine Syndrome
Paraneoplastic Endocrine Syndrome
 
Pitutary part 1
Pitutary part 1Pitutary part 1
Pitutary part 1
 
Pituitary tumours
Pituitary tumoursPituitary tumours
Pituitary tumours
 

Recently uploaded

Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
Esam43
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
AD Healthcare
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 

Recently uploaded (20)

Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 

Pathology of Endocrine system.ppt

  • 1. PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
  • 2. The Endocrine system is divided into : • Endocrine organs dedicated to production of hormones e.g. pituitary,thyroid….etc • Endocrine components in clusters in organs having mixed functions e.g. pancreas, ovary, testes….. • Diffuse endocrine system comprising scattered cells within organs acting locally on adjacent cells without entry into blood stream
  • 3. Disease divided into : 1- Diseases of overproduction of secretion ( Hyperfunction ) 2- Diseases of underproduction ( Hypofunction ) 3- Mass effects ( Tumors ) N.B. Correlation of clinical picture , hormonal assays , biochemical findings , together with pathological picture are of extreme importance in most conditions.
  • 5. PITUITARY GLAND • Pituitary in sella turcica,& weighs about 0.5gm. • Connected to the HYPOTHALAMUS with stalk. • Composed of : A-ADENOHYPOPHYSIS- (80%) – Blood supply is through portal venous plexus – Hypothalamic-Hypophyseal feed back control B- NEUROHYPOPHYSIS – From floor of third ventricle – Modified glial cells & axons hypothalamus. – Has its own blood supply.
  • 6. CELLS & SECRETIONS : A- Anterior pituitary ( Adenohypophysis ) 1-Somatotrophs from acidophilic cells → Growth H. 2- Lactotrophs from chromophobe cells → Prolactin 3- Corticotrophs from basophilic cells → ACTH,MSH . 4- Thyrotrophs from pale basophilic cells → TSH 5- Gonadotrophs from basophilic cells → FSH, LH B- Posterior pituitary ( Neurohypophysis ) 1- Oxytocin 2- ADH
  • 7. HYPERPITUITARISM & PITUITARY ADENOMA In most cases, excess is due to ADENOMA arising in the anterior lobe. Less common causes include : * Hyperplasia * Carcinoma * Ectopic hormone production * Some hypothalamic disorders
  • 8. Pathogenesis of pituitary adenomas : • Mutations in G-proteins ( α subunit) in the GNAS1 gene on chromosome 20q13 lead to activation • 40% of GH secreting adenomas & less in ACTH • G-proteins involved in signal transduction : GDP GTP cAMP • Mutations in α subunit interfere with GTPase function • Mutations in RAS, overexpression in C- MYC & NM23 inactivation found in more aggressive tumor • Other mutations : MEN-1 gene ( Menin) G proteins GTPase
  • 9. Features common to all pituitary adenomas : • 10% of all intracranial neoplasms & 25% incidental 3% occur with MEN syndrome • 30-50 years of age • Primary pituitary adenomas usually benign • May or may not be functional • If functional, the clinical effects are secondary to the hormone produced. • More than one hormone may be produced by same cell • Although most are localized, invasive adenomas erode sella turcica & extend into cavernous & sphenoid sinus
  • 10. CLINICAL FEATURES of PITUITARY ADENOMA: 1- Symptoms of hormone produced 2- Local mass effects : i- Radiological changes ii-Visual field abnormalities iii-Elevated intracranial pressure 3- Hypopituitarism 4- Pituitary apoplexy
  • 11.
  • 12.
  • 13. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) Mass effect of pituitary adenoma
  • 14. Morphology of pituitary adenomas : • Well circumscribed,invasive in up to 30% • Size 1cm. or more, specially in nonfunctioning tumor • Hemorrhage & necrosis seen in large tumors Microscopic picture : • Uniform cells, one cell type (monomorphism) • Absent reticulin network • Rare or absent mitosis
  • 15. Sella turcica with pituitary adenoma
  • 16. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) Uniform cells of pituitary adenoma
  • 17. Types of Pituitary Adenomas • Previously classified according to histological picture e.g : Acidophilic Adenoma • Now according to immunohistochemical findings & clinical picture ….. e.g. Growth hormone secreting adenoma
  • 19. 1- PROLACTINOMA : • 30% of all adenomas, chromophobe or weakly acidophilic • Functional even if small, but related to size • Other causes of  prolactin include : estrogen therapy, pregnancy, reserpine , hypothyroidism…… • Any mass in the suprasellar region may interfere with normal prolactin inhibition   Prolactin ( STALK EFFECT ) • Mild elevation of prolactin does NOT always indicate prolactin secreting adenoma !
  • 20. Symptoms : • Galactorrhea • Amenorrhea • Decrease libido • Infertility
  • 21. 2- Growth hormone secreting adenoma : • 40% Associated with GNAS 1 gene mutation • Persistent secretion of growth hormone leads to secretion of Insulin – like GF → symptoms • Composed of granular ACIDOPHILIC cells • May be mixed with prolactin secretion. • Symptoms delayed so adenomas are usually large • Produce GIGANTISM or ACROMEGALLY • Other symptoms : diabetes, arthritis, large jaw & hands, osteo porosis, BP, HF…..etc
  • 22. 3- Corticotroph cell adenoma • Usually microadenomas • Higher chance of becoming malignant • Chromophobe or basophilic cells • Functionless or Cushing ‘s Disease (  ACTH ) • Bilateral adrenalectomy or destruction may result in aggressive adenoma: Nelson’s Syndrome • Corticotroph microadenoma  Macroadenoma •  ICP
  • 23. 4- Non functioning adenoma 20% silent or null cell ,nonfunctioning & produce mass effect only 5- Gonadotroph producing LH &FSH- ( 10-15%)- Function silent or is minimal , late presentation mainly mass effect produced. Produce gonadotrophin α subunit, β- FSH & β-LH 6- TSH producing ,(1%) rare cause of hyperthyroidism 7- Pituitary carcinoma - Extremely rare, diagnosed only by metastases.
  • 24. HYPOPITUITARISM : • Loss of  75% of ant. Pituitary  Symptoms • Congenital or acquired, intrinsic or extrinsic • Symptoms include dwarfism, & effect of individual hormone deficiencies. Loss of MSH → Decreased pigmentation • Acquired causes include : 1- Nonsecretory pituitary adenoma 2- Ischemic necrosis e.g. SHEEHAN’S SYNDROME (post partum hmg.) sickle cell anemia, DIC, Pituitary apoplexy… 3- Iatrogenic by radiation or surgery 4- Autoimmune ( lymphocytic) hypophysitis 5- Inflammatory e.g sarcoidosis or TB …..
  • 25. 6- Empty Sella Syndrome : Radiological term for enlarged sella tursica, with atrophied or compressed pituitary. May be primary due to downward bulge of arachnoid into sella floor compressing pituitary. Secondary is usually surgical. 7- Infiltrating diseases in adjacent bone e.g. Hand Schuller – Christian Disease 8- Craniopharyngioma
  • 26. Craniopharyngioma : * 1-5 % of intracranial neoplasms * Derived from remnants of Rathke’s Pouch * Suprasellar or intrasellar ,often cystic with calcification * Children or adolescents most affected * Symptoms may be delayed ≥ 20yrs( 50%) * Symptoms of hypofunction or hyperfunction of pituitary and /or visual disturbances, diabetes insipidus * Benign & slow growing
  • 27. POSTERIOR PITUITARY SYNDROMES: 1-A- ADH deficiency causes Diabetes Insipidus Excessive urination,dilute urine , due to inability to reabsorb water from the collecting tubules. Causes include head trauma, tumors & inflammations in pituitary or hypothalamus…etc. B- Syndrome of inappropriate ADH secretion Causes excessive resorption of water hyponatremia e.g Small Cell CA of Lung
  • 28. 2-Abnormal oxytocin secretion : Abnormalitis of synthesis & release have not been associated with any significant abnormality.
  • 30. • Development from evagination of pharyngeal tissue into neck • Abnormal descent Lingual thyroid , subhyoid, substernal • Weight 15-20gm. Responsive to stress • Structure : varying sized follicles lined by columnar epithelium , filled with colloid, interfollicular C cells • Secretion of T3 & T4 is controlled by trophic factors from hypothalamus & ant.pituitary
  • 31. THYROTOXICOSIS: • Hypermetabolic state caused by  T4, T3. A- Associated with hyperthyroidism: Primary : Graves Disease Toxic multinodular goiter Toxic adenoma Secondary : TSH secreting pit. adenoma B- Not associated with hyperthyroidism : Thyroiditis Struma ovarii Exogenous thyroxine intake
  • 32. Clinical Picture related to Sympathetic Stimulation • Constitutional symptoms : heat intolerance, sweating, warm skin, appetite but ↓weight • Gastrointestinal : hypermotility, malabsorption • Cardiac : palpitation, tachycardia, CHF • Menstrual disturbances
  • 33. • Neuromuscular : Tremor, muscle weakness • Ocular : wide staring gaze, lid lag, thyroid ophthalmopathy • Thyroid storm : severe acute symptoms of sympathetic overstimulation • Apathetic hyperthyroidism : incidental
  • 34.
  • 35. Diagnosis of Hyperthyroidism : • Measurement of serum TSH (↓ ) + free T4 is the most useful screening test for thyrotoxicosis • TSH level is normal or  in secondary thyrotoxicosis • In some patients , T3 but T4 normal or ↓ • Measurement of Radioactive Iodine uptake is a direct indication of activity inside the gland
  • 37. HYPOTHYROIDISM : Primary : 1- Loss of thyroid tissue due to surgery or radiation Rx. 2- Hashimoto’s thyroiditis 3- Iodine deficiency specially in endemic areas 4- Primary idiopathic hypothyroidism 5- Congenital enzyme deficiencies 6- Drugs e.g. iodides, lithium….. 7- Thyroid dysgenesis ( developmental ) Secondary : Pituitary or hypothalamic failure
  • 38. Hypothyroidism is commoner in endemic areas of iodine deficiency CRETINISM : hypothyroidism in infancy & is related to the onset of deficiency . If early in fetal life Mental retardation , short stature, hernia, skeletal abnormalities, MYXEDEMA in adults Apathy, slow mental processes, cold intolerence,accumulation of mucopolysaccharides in subcutaneous tissue Lab.tests :  TSH in primary hypothyroidism, unaffected in others T4 in both.
  • 39. THYROIDITIS : • Mostly autoimmune mechanisms • Microbial infection is rare • Types include : 1- Chronic lymphocytic ( Hashimoto’s ) thyroiditis 2- Subacute granulomatous ( de Quervain) thyroiditis 3- Subacute lymphocytic thyroiditis 4- Riedel thyroiditis 5- Palpation thyroiditis
  • 40. HASHIMOTO’s THYROIDITIS : Chronic Lymphocytic Thyroiditis • Autoimmune disease characterized by progressive destruction of thyroid tissue • Commonest type of thyroiditis • Commonest cause of hypothyroidism in areas of sufficient iodine levels • F:M = 10-20 :1, 45-65 yrs. • Can occur in children
  • 41. Pathogenesis : A - T cell sensitization to thyroid antigens 1- Sensitized CD4 T cells  Cytokine mediated ( IFN- γ)cell death inflammation,macrophage activation 2- CD8+ cytotoxic T cell mediated cell death: Recognition of AG on cell  killed 3- Presence of thyroid AB  Antibody dependent cell mediated cytotoxicity by NK cells B- Genetic predisposition : ↑ in relatives of 1st.degree Association with HLA – DR 3 & DR- 5
  • 42. Morphology: • Gland is a smooth pale goitre, minimally nodular, well demarcated. • Microscopically : - Dense infiltration by lymphocytes & plasma cells - Formation of lymphoid follicles, with germinal centers - Presence of HURTHLE CELLS - With or without fibrosis
  • 43. • Clinically : – Painless symmetrical diffuse goiter – May show initial toxicosis ( Hashitoxicosis ). – Later marked hypothyroidism. – Patients have  risk of B-Cell lymphoma
  • 44. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 45. SUBACUTE GRANULOMATOUS THYROIDITIS : • Middle aged , more in females. Viral etiology ? • Self-limited (6-8w) • Acute onset of pain in the neck , fever,  ESR,  WBC • Transient thyrotoxicosis. • Morphology : – Firm gland. – Destruction of acini leads to mixed inflammatory infiltrate. – Neutrophils , Macrophages & Giant cells & formation of granulomas
  • 46. SUBACUTE LYMPHOCYTIC THYROIDITIS : (Silent) • Middle aged females & post partum patients • Probably autoimmune with circulating AB • May recur in subsequent pregnancies • May progress to hypothyroidism • Histology similar to Hashimoto’s thyroiditis without Hurthle cell metaplasia • Reidel’s Thyroiditis – Dense fibrosis without prominent inflammation ? Considered as fibromatosis rather than thyroiditis
  • 47.
  • 48. GRAVE’S DISEASE : • Commonest cause of endogenous hyperthyroidism • Age 20- 40 yrs., • M: F ratio is 1: 7 • More common in western races
  • 49. Main features of GRAVES DISEASE : 1 - Thyrotoxicosis with smooth symmetrical enlargement of thyroid 2 - Infiltrative ophthalmopathy with exophthalmus in 40% 3- Pretibial myxedema in a minority • Lab findings :  T4, T3 , TSH • Radioactive study: Diffuse uptake of radioactive I
  • 50. Pathogenesis of GRAVE’S DISEASE : • Genetic etiology + Autoimmune processes • GENETIC EVIDENCE : • May be familial • 60% concordance in identical twins • Susceptibility is associated with HLA-B8 & - DR3 • May exist with other similar diseases e.g. SLE, Pernicious anemia, Diabetes type I, Addison’s dis.
  • 51. IMMUNE MECHANISMS : • Antibodies to thyroid peroxisomes & thyroglobulin • Patients develop autoantibodies to TSH receptor – Thyroid Stimulating Immunoglobulin ( TSI) binds to TSH receptor → thyroxin *** – Thyroid Growth Stimulating Immunoglobulin (TGI) → proliferation of thyroid epithelium – TSH binding inhibitor immunoglobulins (TBIIs) prevent TSH from binding to receptor • Both stimulation & inhibition may coexist
  • 52. Morphology : • Smooth enlargement of gland with diffuse hyperplasia & hypertrophy • Lining epithelium of acini : Tall & hyperplastic ± papillae • Colloid : Minimal thin colloid with scalloped edge
  • 53. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 54. Changes in Extrathyroid tissue : • Generalized lymphoid hyperplasia • Ophthalmopathy : Edematous orbital muscles &infiltration by lymphocytes followed by fibrosis • Thickening of skin & subcutaneous tissue • Accumulation of glycosaminoglycans which are hydrophilic
  • 55. • Result : Displacement of eyeball & exophthalmus → redness, dryness, ulceration, infection in conjunctiva • Cause : Expression of aberrant TSH receptor responding to circulating anti TSH receptor AB → inflammatory lymphocytic reaction
  • 56. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 15 December 2005 07:30 AM) © 2005 Elsevier
  • 57. DIFFUSE NONTOXIC & MULTINODULAR GOITRE GOITER = Enlargement of thyroid Most common cause is iodine deficiency impaired hormone synthesis TSH  hypertrophy & hyperplasia of follicles  Goiter Endemic :  10% of population have goiter Sporadic : 1- Physiological demand 2- Dietary intake of excessive calcium & cabbages…etc 3- Hereditary enzyme defects
  • 58. MORPHOLOGY : • Initially diffuse → nodular with degenerative changes: colloid cysts, hemorrhage, fibrosis, calcification • If large may extend retrosternally • Pressure symptoms are a common complaint • Picture is that of varying sized follicles, hemorrhage , fibrosis , cysts, calcification • Patient is often EUTHYROID. but may be toxic or hypofunctioning.
  • 59.
  • 61.
  • 62.
  • 63. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 64. NODULES in the thyroid : • Nodules in thyroid may be multiple or solitary • Any solitary nodule in the thyroid has to be investigated as some are neoplastic. Investigations include FNA , Radioactive image technique, Ultrasound, & (T4,T3 & TSH ) levels • HOT nodule takes up radioactive substance ( functional) • COLD nodule does not it take up ( nonfunctional )
  • 65.
  • 66. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 67. General rules of nodules in the thyroid : 1- Solitary nodule is MORE likely to be NEOPLASTIC than multiple 2- Hot nodules are more likely to be BENIGN 3- Not every cold nodule is malignant . Many are nonfuctioning adenomas, or colloid cysts , nodules of nodular goitre….etc Up to 10% of cold nodules prove to be malignant.
  • 68. 4- Nodules in younger patients are more likely to be NEOPLASTIC 5- Nodules in males are more likely to be NEOPLASTIC . 6- History of previous radiation to the neck is associate with increased risk of malignancy
  • 69. NEOPLASMS of the THYROID : ADENOMAS: • Usually single. • Well defined capsule • Commonest is follicular± Hurthle cell change • May be toxic • Size 1- 10cm. Variable colour • Activating somatic mutation in TSH receptor is identified leading to overproduction of cAMP • 20% have point mutation in RAS oncogene
  • 70. Microscopical Picture : • 1- Uniform follicles , lined by cuboidal epithelial cells. • 2- Focal nuclear pleomorphism, nucleoli …. ( Endocrine atypia ) • 3- Presence of a capsule with tumor compressing surrounding normal thyroid outside . * Integrity of capsule is important in differentiating adenoma from well differentiated follicular carcinoma. • Capsular and/ or vascular invasion →Carcinoma
  • 71. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 72. © 2005 Elsevier Adenoma with intact capsule
  • 74. CARCINOMAS of THYROID : • Incidence about 1-2% of all malignancies. • Wide age range ,depending on type. • Generally commoner in females, but in tumors occurring in children or elderly , equal incidence in both sexes. • Most are derived from follicular cells • Few are derived from ‘C’ cells
  • 75. TYPES of THYROID CARCINOMA : 1- Papillary Carcinoma ( 75- 85% ),any age,but usual type in children. 2- Follicular Carcinoma ( 10- 20% )More in middle age 3- Medullary Carcinoma ( 5% ) age 50-60 but younger in familial cases with MEN syndrome 4- Anaplastic Carcinoma (  5% ) , old age Presenting symptom is usually a mass , maybe incidental in a multinodular goitre specially papillary, & follicular
  • 76. Pathogenesis of Thyroid Cancer : 1- Genetic lesions : Most tumors are sporadic Familial is mostly Medullary CA , Papillary CA • Papillary CA : – Chromosomal rearrangement in tyrosin kinase receptor gene (RET) on chr.10q11  ret/PTC  tyrosine kinase activity ( 1/5 of cases specially in children) – Point mutation in BRAF oncogene (1/3-1/2)
  • 77. • Follicular Carcinoma : – RAS mutation in ½ of cases OR – PAX8- PPAR γ 1 fusion gene in 1/3 of cases • Medullary Carcinoma : – RET mutation  Receptor activation • Anaplastic Carcinoma : – Probably arising from dedifferentiation of follicular or papillary CA  inactivation of P53
  • 78. 2- Environmental Factors : • Ionizing radiation specially in first two decades • Most common is Papillary CA. with RET gene rearrangement 3- Preexisting thyroid disease : • Incidence of thyroid CA is more in endemic areas • Long standing multinodular goiter → Follicular CA • Hashimotos thyroiditis → Papillary CA & B cell lymphoma
  • 79. • TYPES OF THYROID CARCINOMAS
  • 80. PAPILLARY CARCINOMA : • Cold on Scan by radioactive Iodine • Solitary or multifocal • Solid or cystic,  calcification • Composed of papillary architecture • Less commonly ‘Follicular Variant’
  • 81. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 82. Diagnosis based on NUCLEAR FEATURES • Nuclei are clear (empty) ,with grooves & inclusions ( Orphan Annie nuclei) • Psammoma bodies • Metastases mainly by L.N., sometimes from occult tumor • Hematogenous spread late & prognosis is GOOD
  • 83. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier FNA of Papillary CA (nuclear changes)
  • 84.
  • 85. Psammoma body in Papillary CA
  • 86. FOLLICULAR CARCINOMA : • Usually cold but rarely functional ( warm ) • Well circumscribed with thick capsule (minimally invasive) or diffusely infiltrative • Composed of follicles , sometimes of Hurthle Cells • Diagnosis is based on CAPSULAR & VASCULAR invasion
  • 87. • Metastasize usually by blood  Lungs, Bone, Liver ..etc. • Treatment by surgery  Radioactive Iodine  Thyroxin • Prognosis is not as good as papillary except in minimally invasive very well differentiated forms
  • 88. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Follicular Carcinoma
  • 89. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Capsular invasion)
  • 90. MEDULLARY CARCINOMA: • Arise from C cells  CALCITONIN, CEA, serotonin, VIP • 80% Sporadic , or familial  MEN Syndrome • Composed of polygonal or spindle cells , usually with demonstrable AMYLOID in the stroma • Calcitonin demonstrated in tumor cells
  • 91. • Level of calcitonin in serum may be useful for follow up • Family members may show C cell hyperplasia ,↑ Calcitonin, & RET mutation ( Marker for early diagnosis) • Metastases by blood stream • Prognosis intermediate , worse in MEN. 2B
  • 92. Medullary CA with amyloid
  • 93. Congo red for amyloid
  • 94. ANAPLASTIC CARCINOMA : • Elderly patients with multinodular goitre in 50% • Foci of papillary or follicular CA may be present in 20%- 30% , probable dedifferentiation process • Markedly infiltrative tumor , invading the neck → pressure on vital structures • Rapid progression, death within 1 year
  • 95. • Morphology : Composed of pleomorphic giant cells, spindle cells or small cell anaplastic varients, which may be confused with lymphoma • Radiosensitive tumor , no surgery • P53 mutation identified , consistent with tumor progression
  • 96. PARATHYROID GLAND • Derived from the third and fourth pharyngeal pouches. • 90% of people have four glands. • Location: mostly close to the upper or lower poles of the thyroid. • Can be found anywhere along the line of descent of the pharyngeal pouches. • There are two types of cells with intervening fat : - Chief & Oxyphil cells • Secretion of PTH is controlled by level of free calcium
  • 97. Hyperparathyroidism : Primary OR Secondary Primary Hyperparathyroidism: • Commonest cause of asymptomatic hypercalcemia • Female:Male ratio = 2-3 : 1. • Causes : Adenoma 75%-80% Hyperplasia 10-15% Carcinoma < 5% • Majority of adenomas are sporadic • 5% familial associated with MEN-1 or MEN-2A
  • 98. Genetic abnormalities : • PRAD 1 on chromosome 11 q  cell cycle control  cyclin D1 overexpression(10%-20%) • MEN 1 on 11q13 is a cancer suppressor gene - Germ line mutation in MEN-1 syndrome  loss of function  cell proliferation - *20% - 30% of sporadic cases may also show mutation of MEN1 *Either of above may cause tumor or hyperplasia
  • 99. • Biochemical findings : PTH ,  Ca , ↓ phosphate ,alkaline phosphatase • In other causes of hypercalcemia, PTH is ↓
  • 100. Gland morphology in Hyperparathyroidism • Adenomas : • Usually single , rarely multiple • Well circumscribed, encapsulated nodule (0.5-5g.) • The cells are polygonal, uniform chief cells, few oxyphil cells. Adipose tissue is minimal in the tumor • Compressed surrounding parathyroid tissue in periphery, other glands normal or atrophic .
  • 101.
  • 102. • Hyperplasia : Enlargement of all 4 glands. Microscopically chief cell hyperplasia, or clear cell, usually, in a nodular or diffuse pattern. Note : Diagnosis of adenoma versus hyperplasia may depend on the size of the other glands
  • 103. Parathyroid carcinoma : • Larger than adenoma (5-10g) • Very adherent to surrounding tissue. • Pleomorphism & mitoses not reliable criteria for malignancy • Most reliable criteria for malignancy are : * Invasion **Metastases
  • 104. Morphology in other organs: • Skeletal system: – Bone resorption by osteoclasts, with fibrosis, cysts formation and hemorrhage Osteitis Fibrosa Cystica – Collections of osteoclasts form ‘ Brown Tumors” – Chondrocalcinosis and pseudogout may occur. • Renal system: – Ca. Stones. & Nephrocalcinosis. • Metastatic calcification in other organs: Blood vessels & myocardium , Stomach, Lung …etc
  • 105. Hyperparathyroidism, clinical picture • 50% of patients are asymptomatic. • Patients show  Ca & PARATHORMONE levels in serum • Symptoms and signs of hypercalcemia: Musculoskeletal, Gastrointestinal tract, Urinary and CNS symptoms • Commonest cause of silent hypercalcemia . • In the majority of symptomatic hypercalcemia commonest cause is wide spread metastases to bone
  • 106. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Painful Bones, Renal Stones, Abdominal Groans & Psychic Moans
  • 107. Secondary Hyperparathyroidism : • Occur in any condition associated with chronic hypocalcemia, mostly chronic renal failure. • Glands are hyperplastic • Renal failure phosphate excretion  increased serum phosphate,  CaPTH
  • 108. Tertiary Hyperparathyroidism • Extreme activity of the parathyroid  autonomous function & development of adenoma (needs surgery)
  • 109. Hypoparathyroidism : • Causes: – Damage to the gland or its vessels during thyroid surgery. – Idiopathic, autoimmune disease. – Pseudohypoparathyroidism, tissue resistance to PTH • Clinical features: -Tetany, convulsion, neuromuscular irritability, cardiac arrhythmias……
  • 111. • Diseases mainly include : – Diabetes – Islet Cell Tumors
  • 113. DIABETES : • Chronic disorder in which there is abnormal metabolism, of carbohydrate, fat & protein , characterized by either relative or absolute insulin deficiency, resulting in hyperglycemia. • Most important stimulus that triggers insulin synthesis from β cells is GLUCOSE • Other agents stimulate insulin release • Level of insulin is assessed by the level of C - peptide
  • 114. • Diagnosis : 1- Random glucose ≥ 200g / dL + symptoms 2- Fasting glucose of ≥ 126 / dL on more than one occasion 3- Abnormal OGTT when glucose level is more than 200g / dL 2hrs. after standard glucose load of 75 g.
  • 115. Classification : Causes could be Primary in the pancreas OR secondary to other disease conditions Primary diabetes is classified into : A- Type 1 B- Type 2 C- Genetic & Miscellaneous causes Whatever the type, complications are the same
  • 116. Type 1 :- • Absolute deficiency of insulin due to β cell destruction ( 10%) •  90% of  cells lost before metabolic changes appear • Age ≤ 20 yrs but may be latent • Normal or decreased weight • Ketoacidosis is common
  • 117. Type 2 : • Due to a combination of peripheral resistance to insulin action & inadequate secretory response by the pancreatic β cells • Commoner ( 80 - 90% ) • Insulin normal (relative insulin deficiency) • Patient is overweight • Rare ketoacidosis
  • 118. Type 3 : Miscellaneous causes • Genetic defects : – β cell function e.g. Maturity Onset Diabetes of the Young ( MODY)caused by a variety of mutations – Genetic defects of insulin processing or action e.g. Insulin gene or Insulin receptor mutations
  • 119. Secondary Miscellaneous Causes : • Diseases of exocrine pancreas e.g. chronic pancreatitis • Endocrinopathies e.g. Cushing’s Syndrome, Acromegally • Infections e.g. CMV • Drugs e.g. glucocorticoids • Gestational diabetes • Other genetic syndromes associated with diabetes
  • 121. Pathogenesis of Type 1 Diabetes : 1- Genetic susceptibility 2- Autoimmunity 3- Environmental factors It is a combination of autoimmunity & environmental insult in a person with a known genetic susceptibility leading to destruction of β cells
  • 122. 1- Genetic susceptibility – Principal susceptibility genes located in region of MHC class II on chromosome 6p21 – 90% Associated with HLA- DR3,or HLA- DR4, or both – Racial predisposition, (Caucasians) but majority have no family history – 6- 20% familial ,< 40% in identical twins – Second susceptibility gene encodes a T cell inhibitory receptor (CTLA-4) interfering with normal T cell function
  • 123. 2- Autoimmunity - • Presence of CD 8+ & CD 4+ in islet cells “ Insulinitis” • Presence of islet cell antibodies ( insulin & GAD) in 80% of patients & in relatives several months or years before onset • Antibodies are highly selective against β cells • Relatives at risk have similar AB years before onset • 10% - 20% other autoimmune disease
  • 124. 3- Environmental factors An environmental insult may damage β cells rendering them antigenic. • Viruses : measles , coxsackie , rubella • Chemicals • Cow’s milk
  • 125. Pathogenesis of Type 2 diabetes : 1- Genetic factors 2- Insulin resistance & obesity 3 - cell secretion dysfunction
  • 126. 1- Genetic factors : – Genetic factors are more important than in type 1 diabetes, but this is multifactorial – 50% - 90% in identical twins –  risk by 20%-40% in first degree relatives – No association with HLA & no autoimmune basis – Point mutation in insulin receptor identified affecting signaling pathway but rare ( 1-5%)
  • 127. 2 – Insulin resistance : • Decrease ability of peripheral tissue to respond to insulin Early : insulin resistance →  insulin secretion due to compensatory  of  cell mass Later : relative  insulin &   cell mass to 20-50% MAIN FACTOR IN INSULIN RESISTANCE IS OBESITY
  • 128. Explanation : • Adipocytokines : – Resistin ↑ obesity → Insulin resistance – Leptin & Adiponectin contribute to insulin sensitivity but are ↓in obesity → resistance – PPAR γ is a nuclear receptor that regulates level of adipocytokines – FFA in tissues (lipotoxic effect) →  insulin resistance
  • 129. 3-  cell Dysfunction : • Defective glucose recognition due to ↑ intracellular levels of a mitochondrial protein ( UCP2) in β cells • Amylin : A protein normally produced by  cells secreted with insulin in response to food ingestion Amylin accumulates outside  cells, forming amyloid like deposits & may impair  cell glucose sensing. Seen in up to 90% of cases of Type II diabetes
  • 130. Pathogenesis of complications : 1- Nonenzymatic glycosylation of proteins Glucose + Free amino acids Later → Irreversible combination Advanced Glycosylation End products =AGES Measured by level of glycosylated Hb ( HbA1c) AGES inactivate proteins & cross link with more proteins, deposited in vessels, renal glomeruli, …..etc
  • 131. Effects : Induce cytokine production, GF : • ↑ vascular permeability • ↑ procoaggulant activity • ↑ fibroblasts & SM in ECM Complications in blood vessels, kidney, nervous system ….etc Complications are proportional to the degree of hyperglycemia of whatever type
  • 132. 2- The Polyol Pathway Persistent hyperglycemia facilitates entry of glucose & its accumulation into some cells & metabolized into  SORBITOL (a polyol) & FRUCTOSE Creation of osmotic gradient  Influx of fluid + Toxic lens, retina, peripheral nerves, kidney…etc
  • 133. 3- Activation of Protein Kinase C : • Activation of signal transduction • Leads to production of pro-angiogenic factors (VEGF) Important in retinal neovascularization • Production of pro-fibrogenic factors → ↑ECM & BM thickening
  • 135. Pathology in the Pancreas i -Type I : - Leukocytic infiltration of islets ( T cells) ‘Insulinitis’ with progressive depletion of  cells. - Later small indistinct or absent islets. ii - Type II : - Ill defined reduction in islet cell mass - Fibrous tissue accumulation in some islets - Amyloid deposition in islets • Newborn of diabetic mother : islet cell hyperplasia
  • 136.
  • 137.
  • 139. 1- Atherosclerosis : - Cardiovascular - CNS complications - Peripheral circulation 2- Diabetic microangiopathy - Hyaline arteriolosclerosis , exaggerated in hypertension - Diffuse thickening in capillaries of skin, retina peripheral nerves, renal medulla → Leaky vessels→ nephropathy, retinopathy, neuropathy
  • 140. 3- Diabetic nephropathy I - Glomerular lesions- - Capillary BM thickening - Nodular glomerulosclerosis 15% -30% ( Kimmelstiel - Wilson lesion) - Diffuse mesangial sclerosis II - Renal vascular lesions - Renal atherosclerosis - Hyaline arteriolosclerosis
  • 141. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Kimmelstiel- Wilson lesion
  • 142. III – Pyelonephritis - Acute & chronic interstitial inflammation - Necrotizing papillitis / papillary necrosis
  • 143. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 144. 4- Ocular complications : I - Retinopathy : - Nonproliferative : hemorrhage, exudate, microaneurysm, edema… - Proliferative : Neovascularization, fibrosis, retinal detachment II - Cataract formation III - Glaucoma
  • 145. 5- Diabetic neuropathy I - Peripheral sensory & autonomic nerve dysfunction ( microangiopathy & demyelination ) II - Neuronal degeneration III - Degenerative spinal cord lesions 6- Recurrent infections : Bacterial & mycotic
  • 146. • Clinical Features in Diabetes : Type 1 : • Age < 20 , but some are latent (LADA) • May present with metabolic acidosis, weight loss, dehydration,& electrolyte imbalance. Polyuria , Polydipsia, Polyphagia ( 3P’s) • Findings : - Hyperglycemia - Glucosuria ± Ketonuria - Electrolyte imbalance
  • 147. Type 2 : • Age > 40yrs., often present incidentally • Patients may have the 3 P’s  symptoms of complications • Hyperosmolar nonketotic coma caused by dehydration due to uncompensated hyperglycemic diuresis. • No keto acidosis • Increased susceptibility to infections
  • 149. Islet Cells & Secretions : • β cells  insulin • α cells  glucagon • δ cells  somatostatin • Pancreatic polypeptide ( PP)  VIP
  • 150. Islet Cell Tumors of Pancreas : • Include insulinomas, gastrinomas, glucagonomas….etc • Less frequent than pancreatic CA • Maybe functioning or nonfunctioning • Tumors ≤ 2 cm. diameter likely to be benign • Associated clinical syndromes : 1- Hyperinsulinism (Insulinomas) 2- Zollinger - Ellison Syndrome ( Gastrinomas) 3- Multiple endocrine neoplasia (MEN)
  • 151. Insulinoma : • Commonest type • Hypoglycemia ≤ 50 mg./dl. • Attack precipitated by fasting or exercise, relieved by eating or glucose administration • Lab. :  serum glucose , serum insulin • Most tumors in pancreas but can be ectopic • Most tumors solitary ( < 2cm.), can be multiple • Majority are benign, 10% can be malignant • Histologically difficult to diagnose malignancy
  • 152. Gastrinomas : • More in middle aged females • Located in pancreas , duodenum or peripancreatic tissue • Single or multiple, or associated with other tumors • > 50% locally invasive or have metastasized at diagnosis • Present with Zollinger- Ellison Syndrome
  • 153. Zollinger - Ellison Syndrome : – Peptic ulcer disease – Ulcer features : Multiple ulcers Unusual locations specially jejunum Intractable – Gastrin hypersecretion – Diarrhea in > 50% & may be the presenting symptom
  • 154. Rare tumors : • α- Cell tumors : Middle aged women Glucagon secretion , mild diabetes, skin rash, anemia • δ- Cell tumors : Somatostatin secretion  Diabetes, malabsorption, GB stones… • VIPomas : VIP secretion  Watery diarrhea, hypokalemia, achlorhydria
  • 156. ADRENAL GLAND • Weight of normal gland is 4 gm. Adrenal Cortex - Derived from mesoderm & composed of 1- Zona glomerulosamineralocorticoids (aldosteron) 2- Zona fasciculata  glucocorticoids ( cortisol ) 3- Zona reticularis  estrogens & androgens • Diseases are those of hyperfunction & hypofunction & tumors
  • 157. Adrenal Medulla – • Derived from neural crest & is part of sympathetic system. • Composed of Chromaffin cells secreting catecholamines • Diseases are mainly tumors
  • 158. Congenital Anomalies • Incidental finding of adrenal tissue in the inguinoscrotal path , mainly in males • Fusion of adrenals • Congenital adrenal hyperplasia • Ectopic tissue in adrenal : liver, thyroid & ovarian tissue
  • 159. ADRENOCORTICAL HYPERFUNCTION : • There are 3 syndromes associated with hyperfunction: 1- Cushing’s Syndrome & Cushing’s Disease 2- Conn’s Syndrome & Hyperaldosteronism 3- Adrenogenital Syndrome
  • 160. CUSHING’Syndrome • Elevation of cortisol level , which occurs in one of four ways A- Endogenous causes : i- ACTH*secreting pituitary microadenoma, few macroadenomas, OR hyperplasia (CUSHING’s DISEASE) ii-Adrenal tumor or hyperplasia iii- Paraneoplastic syndrome
  • 161. B- Exogenous cause : Steroid Therapy Tests used are : Level cortisol in plasma,or excretion of 17hydroxy steroids in urine, diurnal pattern , level of ACTH, & Dexamethasone Suppression test.
  • 162. Morphology of adrenals in Cushing’s Syndrome : • This depends on the cause : 1- Exogenous increase glucocorticoids ACTH Bilateral atrophy of adrenals 2 -Endogenous hypercorticolism: a- Presence of adrenal adenoma or carcinoma, with atrophy of adjacent & contralateral adrenal b- Secondary to ACTH secreting adenoma bilateral diffuse or nodular hyperplasia c- Primary adrenal nodular hyperplasia
  • 163.
  • 164. The pituitary in all forms of Cushing’s syndrome shows Alteration in ACTH producing cells : • Granular basophilic cells show lighter homogenized cytoplasm due to accumulation of intermediate keratin filaments in cytoplasm , called : • Crooke’s Hyaline Change
  • 165. Clinical features of Cushing’s syndrome : Main symptoms include : Central obesity/ moon face Hypertension Hirsutism/ menstrual disturbances Diabetes Osteoporosis Increased risk of infections Pigmentation of skin
  • 166.
  • 167. HYPERALDOSTERONISM : • Excess level of aldosterone cause sodium retension, potassium excretion, resulting in hypertension & hypokalemia. • Type could be primary OR secondary
  • 168. A- Primary : Conn Syndrome • Caused by Adenoma (80%) F:M is 2:1 Single or multiple • Or primary adrenal hyperplasia ( 15% ) , • Carcinoma is rare • Adjacent adrenal cortex is NOT atrophic • There is aldosteron Na retention & K excretion  BP , Hypokalemia , RENIN Correctable cause of HYPERTENSION
  • 169. B- Secondary : Due to decreased renal perfusion, activation of the renin - angiotensin system  aldosteron • Differentiate from primary by  RENIN
  • 170. VIRILIZING Syndromes : Could be caused by - primary gonadal disorders - Adrenocortical Neoplasms - Congenital adrenal hyperplasia • Neoplasms can occur at any age, frequently malignant • Congenital adrenal hyperplasia is caused by an enzyme defect in cortisol synthesis (21 hydroxylase) NO CORTISOLACTH androgenic steroids • Virilization , precocious puberty, ambiguous genitalia • Patients have risk for acute adrenocortical insufficiency
  • 171. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 172. MORPHOLOGY in ALL ADRENAL TUMORS: • Encapsulated , usually yellow • Size variable 1-2 cm. ( 30gms.)Up to large tumors • Most incidental nonfunctioning tumors, may be functioning • Malignant tumors with necrosis, hemorrhage (≥ 300gms) • Usually larger , more aggressive in adults • Both may show same appearance of uniform or slightly pleomorphic cells ,may be eosinophilic or clear • Local invasion ,& the presence of metastases differentiate benign from malignant tumors
  • 173. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Cortical Adenoma
  • 175. ADRENOCORTICAL INSUFFICIENCY : • May be primary adrenal or secondary to destruction of the pituitary as in SHEEHAN’s syndrome….etc • Primary in adrenal may be : A- Acute : 1- Massive adrenal hemorrhage as in anticoaggulant therapy, DIC, sepsis by N.meningitidis,pseudomonas ( Waterhouse- Friderichsen syndrome) 2- Sudden withdrawal of steroid therapy 3- Stress in a pt.with underlying chronic insufficiency
  • 176. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Adrenal hemorrhage
  • 177. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier
  • 178. Adrenal insufficiency (continued ) B- Chronic :( Addison’s disease ) Progressive destruction of the adrenal by : 1- Autoimmune Disorder: 75-90 % , may be sporadic or familial, linked to HLA-B8 , DR3, HLA-DQ5 Often multisystem involvement 2- Infections e.g. Tuberculosis , fungii ( AIDS) 3- Metastatic tumors destroying adrenal e.g. lung, breast , …others
  • 179. Morphology & Clinical features in Chronic Adrenal Insufficiency : • Morphology depends on cause : • Autoimmune : Irregular small glands, cortex infiltrated by lymphocytes, medulla normal. • T.B. Caseating Granuloma • Metastatic disease  Type of primary tumor • Secondary to pituitary cause : the adrenal is shrunken
  • 180. • Clinical features : Weight loss, hypotension, hypoglycemia, pigmentation…. There is Hyperkalemia & Hyponatremia due to ↓ mineralocorticoids
  • 181. THE ADRENAL MEDULLA : • Composed of CHROMAFFIN CELLS & nerve endings • Secretetes cholamines in response to sympathetic stimulation • Also present in extra-adrenal sites • Pathology includes tumors : A- Pheochromocytoma B- Neuroblastoma
  • 182. PHEOCHROMOCYTOMA : • Secretes catecholamines → VMA • Sometimes described as The 10% Tumor because : * 10% bilateral * 10% extra adrenal ( Paraganglioma) * 10% familial, maybe part of MEN syndrome * 10% Malignant • Usually well circumscribed,small to large in size,maybe pleomorphic. Malignancy confirmed by METASTASES • Clinically sustained or paroxysmal attacks of  BP • CORRECTABLE cause of HYPERTENSION
  • 183. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM) © 2005 Elsevier Pheochromocytoma
  • 184. NEUROBLASTOMA : • Commonest extracranial solid tumor of childhood • Usually adrenal but maybe extra-adrenal • Familial or sporadic • Associated with deletion of short arm of chromosome 1 • 90% associated with catecholamine secretion • VMA excreted in 24 hr. urine helpful in diagnosis. • Morphologically it is composed of small round blue cells which may differentiate to ganglion cells • Spread to adjacent organs, lymph nodes, renal vein. • Prognosis : STAGE , AGE , N myc amplification
  • 186. POLYGLANDULAR SYNDROME : • Autoimmune disease • Familial or sporadic – Isolated involvement of adrenals – Multiorgan involvement • Type I : autosomal recessive associated with mutation on immune regulator gene on Chr. 21 • Type II : multifactorial, linked to HLA-B8 , HLA-DR3 , HLA-DQ5 – Include Hashimoto’s thyroiditis,adrenalitis, diabetes type I, pernicious anemia
  • 187. MEN SYNDROME : • Inherited syndrome with multiple endocrine tumors & or hyperplasia of component cells • Tumors occur at younger age • Often preceded by asymptomatic OR symptomatic hyperplasia in involved organ • Tumors may be multifocal in the same organ • Often more aggressive than the same tumor without MEN syndrome
  • 188. Types of MEN syndromes : • Type MEN 1 : ( 3 Ps) • Autosomal dominant • Involves suppressor gene on 11q.13 – Parathyroid : multiglandular parathyroid hyperplasia (95%] – Pancreas: aggressive,multifocal functional gastrinomas & insulinomas – Pituitary: Prolactinoma ± GH
  • 189. Type MEN 2 : • Autosomal dominant Proto-oncogen mutation : RET/10q 11 • MEN 2 A : – Medullary carcinoma of thyroid + C cell hyperplasia – Pheochromocytoma (50%) – Parathyroid hyperplasia • MEN 2 B : – As above but no parathyroid hyperplasia – Extra endocrine manifestations : e.g. mucosal neurofibromas